Cochlear Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$1.71 |
Market Cap |
$8.78 B |
Shares Outstanding |
115.43 M |
Public Float |
- |
Cochlear Ltd. | |
Stock Exchange | Other OTC |
EPS |
$3.42 |
Market Cap |
$8.29 B |
Shares Outstanding |
57.66 M |
Public Float |
- |
Cochlear Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD4.57 |
Market Cap |
AUD12.59 B |
Shares Outstanding |
57.72 M |
Public Float |
57.37 M |
Address |
1 University Avenue Sydney New South Wales (NSW) 2109 Australia |
Employees | - |
Website | http://www.cochlear.com |
Updated | 07/08/2019 |
Cochlear Ltd. engages in the provision of implantable hearing solutions. It operates through following segments: Americas; Europe, Middle East & Africa; and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. |